EZR and rhabdomyosarcoma: Similar reports have shown that overexpressing ezrin antisense [13] or an ezrin T567A dominant-negative mutant [14] blocks both experimental and spontaneous metastasis of murine rhabdomyosarcoma and osteosarcoma cells, and in the latter report the rate-limiting effect was demonstrated to be on early survival of metastastic cells.